MgSO4 prophylaxis for obstetric reasons: Traditional solutions vs ready-made solutions
MgSO4 prophylaxis for obstetric reasons: Traditional solutions vs ready-made solutions
Aim: Magnesium (Mg) is frequently used in obstetrics as an anticonvulsant and neuroprotection in daily practice. Although readymadesolutions are produced today, health care workers still prepare and use MgSO4 via traditional methods. We planned this studyto investigate the possible benefits of using ready-made solutions.Material and Methods: The solution prepared by traditional methods was compared to a ready-made solution in terms of Mg amount,preparation duration and cost over time.Results: Ready-made solutions resulted in a more homogeneous infusion (386.98±25.30 vs 402.65±21.68), lower cost (6.86 vs 5.56)and less labor loss (1258 (min: 900 – max: 1500) vs 0 sec).Conclusions: This study, it does show that the use of a ready-made solution allows the patient to receive a more homogenousinfusion of magnesium over time, and it is more financially profitable. The use of ready-made MgSO4 solution also prevents the lossof time in the labor force that would have been spent preparing the solution.
___
- 1. Gupta K, Vohra V, Sood J. The role of magnesium as
an adjuvant during general anaesthesia. Anaesthesia
2006;61:1058-63.
- 2. Gröber U, Schmidt J, Kisters K. Magnesium in prevention
and therapy. Nutrients 2015;7:8199-226.
- 3. Hilmy MI, Somjen GG. Distribution and tissue uptake of
magnesium related to its pharmacological effects. Am J
Physiol 1968;214:406-13.
- 4. Hoane MR. Assessment of cognitive function following
magnesium therapy in the traumatically injured brain.
Magnes Res 2007;20:229-36.
- 5. Goni-de-Cerio F, Alvarez A, Lara-Celador I, et al. Magnesium
sulfate treatment decreases the initial brain damage
alterations produced after perinatal asphyxia in fetal lambs.
J Neurosci Res 2012;90:1932-40.
- 6. Sameshima H, Ikenoue T. Long-term magnesium sulfate
treatment as protection against hypoxic-ischemic
brain injury in seven-day-old rats. Am J Obstet Gynecol
2001;184:185-90.
- 7. Esen F, Erdem T, Aktan D, et al. Effects of magnesium
administration on brain edema and blood-brain barrier
breakdown after experimental traumatic brain injury in rats.
J Neurosurg Anesthesiol 2003;15:119-25.
- 8. Duley L, Gulmezoglu AM, Henderson-Smart DJ, et al.
Magnesium sulphate and other anticonvulsants for
women with pre-eclampsia. Cochrane Database Syst Rev
2010;CD000025.
- 9. Nguyen TM, Crowther CA, Wilkinson D, et al. Magnesium
sulphate for women at term for neuroprotection of the fetus.
Cochrane Database Syst Rev 2013;2:CD009395.
- 10. Turkish Pharmaceutical Guide website. Available to
(15.12.2018): https://www.ilacrehberi.com/v/pre-eklamolmagnezyum-
sulfat-40-g1000-ml-iv-infuz-1036b/
- 11. Thurnau GR, Kemp DB, Jarvis A. Cerebrospinal fluid levels
of magnesium in patients with preeclampsia after treatment
with intravenous magnesium sulfate: a preliminary report.
Am J Obstet Gynecol 1987;157:1435-8.
- 12. Fong J, Gurewitsch ED, Volpe L, et al. Baseline serum and
cerebrospinal fluid magnesium levels in normal pregnancy
and preeclampsia. Obstet Gynecol 1995;85:444-8.
- 13. Apostol A1, Apostol R, Ali E, et al. Cerebral spinal fluid
and serum ionized magnesium and calcium levels in
preeclamptic women during administration of magnesium
sulfate. Fertil Steril 2010;94:276-82.
- 14. Sevene E, Lewin S, Mariano A, et al. Systems and market
failures: the unavailability of magnesium sulphate for the
treatment of eclampsia and pre-eclampsia in Mozambique
and Zimbabwe. BMJ 2005;331:765-9.
- 15. Langer A, Villar J, Tell K, et al. Reducing eclampsia-related
deaths - a call to action. Lancet 2008;371:705-6.
16. Neilson JP. Magnesium sulphate: the drug of choice in
eclampsia. BMJ 1995;311:701-3.